HK1063322A1 - 1-Glyoxlylamide indolizines for treating cancer. - Google Patents

1-Glyoxlylamide indolizines for treating cancer.

Info

Publication number
HK1063322A1
HK1063322A1 HK04106091A HK04106091A HK1063322A1 HK 1063322 A1 HK1063322 A1 HK 1063322A1 HK 04106091 A HK04106091 A HK 04106091A HK 04106091 A HK04106091 A HK 04106091A HK 1063322 A1 HK1063322 A1 HK 1063322A1
Authority
HK
Hong Kong
Prior art keywords
substituted
group
unsubstituted
independently
aryl group
Prior art date
Application number
HK04106091A
Other languages
English (en)
Inventor
Keizo Koya
Lijun Sun
Mitsunori Ono
Weiwen Ying
Hao Li
Original Assignee
Synta Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synta Pharmaceuticals Corp filed Critical Synta Pharmaceuticals Corp
Publication of HK1063322A1 publication Critical patent/HK1063322A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
HK04106091A 2001-09-13 2004-08-13 1-Glyoxlylamide indolizines for treating cancer. HK1063322A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32202001P 2001-09-13 2001-09-13
PCT/US2002/029154 WO2003022846A1 (en) 2001-09-13 2002-09-13 1-glyoxlylamide indolizines for treating cancer

Publications (1)

Publication Number Publication Date
HK1063322A1 true HK1063322A1 (en) 2004-12-24

Family

ID=23253054

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04106091A HK1063322A1 (en) 2001-09-13 2004-08-13 1-Glyoxlylamide indolizines for treating cancer.

Country Status (20)

Country Link
US (2) US6861436B2 (ko)
EP (1) EP1432709B8 (ko)
JP (1) JP2005504795A (ko)
KR (1) KR20040053125A (ko)
CN (1) CN1568324A (ko)
AT (1) ATE300542T1 (ko)
AU (1) AU2002333626B2 (ko)
BR (1) BR0212794A (ko)
CA (1) CA2459886A1 (ko)
DE (1) DE60205265T2 (ko)
ES (1) ES2245747T3 (ko)
HK (1) HK1063322A1 (ko)
IL (1) IL160810A0 (ko)
IS (1) IS7176A (ko)
MX (1) MXPA04002323A (ko)
NO (1) NO20041035L (ko)
NZ (1) NZ531700A (ko)
PT (1) PT1432709E (ko)
WO (1) WO2003022846A1 (ko)
ZA (1) ZA200401996B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE300542T1 (de) * 2001-09-13 2005-08-15 Synta Pharmaceuticals Corp 1-glyoxlylamidindolizine zur behandlung von krebs
US20040116462A1 (en) * 2002-12-12 2004-06-17 Mitsunori Ono Indolizine compounds
JP2006504692A (ja) * 2002-09-13 2006-02-09 シンタ ファーマシューティカルズ コーポレーション インドリジンの合成方法
DE10318611A1 (de) 2003-04-24 2004-11-11 Elbion Ag 4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
WO2005099824A1 (en) * 2004-03-30 2005-10-27 Synta Pharmaceuticals, Corp. 1-glyoxylamide indolizines for treating lung and ovarian cancer
GB0413605D0 (en) 2004-06-17 2004-07-21 Addex Pharmaceuticals Sa Novel compounds
US20070293456A9 (en) * 2004-12-30 2007-12-20 Anthony Hayford Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds
WO2006128184A2 (en) * 2005-05-20 2006-11-30 Alantos-Pharmaceuticals, Inc. Pyrimidine or triazine fused bicyclic metalloprotease inhibitors
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
WO2010019796A1 (en) * 2008-08-14 2010-02-18 Chemietek, Llc Heterocyclic amide derivatives as ep4 receptor antagonists
CN104042617A (zh) 2009-04-29 2014-09-17 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法
AR077428A1 (es) * 2009-07-29 2011-08-24 Sanofi Aventis (aza) indolizinacarboxamidas ciclicas su preparacion y su uso como agentes farmaceuticos
CN113603694B (zh) * 2021-07-16 2022-07-22 浙江工业大学 一种1,2-二酮类化合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2287706A (en) 1994-03-21 1995-09-27 Fujisawa Pharmaceutical Co Indolizine derivatives
FR2757166B1 (fr) * 1996-12-12 1999-01-29 Rhone Poulenc Rorer Sa Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
WO1998047507A1 (en) 1997-04-24 1998-10-29 Shionogi & Co., Ltd. Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds
EP1085021A4 (en) 1998-05-21 2003-01-08 Shionogi & Co DERIVATIVES OF PYRROLO 1,2-B] PYRIDAZINE, WITH INHIBITOR EFFECT ON SPLA 2?
WO2000021563A1 (fr) 1998-10-14 2000-04-20 Shionogi & Co., Ltd. Moyens de traitement et de prevention contre les troubles ischemiques dus a la repercussion
US6461538B2 (en) * 1999-12-16 2002-10-08 Fuji Photo Film Co., Ltd. Production process for indolizine compounds and their use in organic light-emitting devices
ATE300542T1 (de) * 2001-09-13 2005-08-15 Synta Pharmaceuticals Corp 1-glyoxlylamidindolizine zur behandlung von krebs
US20040116462A1 (en) * 2002-12-12 2004-06-17 Mitsunori Ono Indolizine compounds

Also Published As

Publication number Publication date
ZA200401996B (en) 2005-05-31
US20030153759A1 (en) 2003-08-14
IL160810A0 (en) 2004-08-31
DE60205265D1 (de) 2005-09-01
NO20041035L (no) 2004-04-30
PT1432709E (pt) 2005-10-31
IS7176A (is) 2004-03-11
ES2245747T3 (es) 2006-01-16
DE60205265T2 (de) 2006-03-30
JP2005504795A (ja) 2005-02-17
AU2002333626B2 (en) 2006-06-29
CA2459886A1 (en) 2003-03-20
CN1568324A (zh) 2005-01-19
EP1432709B1 (en) 2005-07-27
EP1432709B8 (en) 2005-11-02
WO2003022846A1 (en) 2003-03-20
MXPA04002323A (es) 2005-04-08
ATE300542T1 (de) 2005-08-15
US20040214850A1 (en) 2004-10-28
US6861436B2 (en) 2005-03-01
EP1432709A1 (en) 2004-06-30
BR0212794A (pt) 2004-10-05
KR20040053125A (ko) 2004-06-23
NZ531700A (en) 2006-10-27

Similar Documents

Publication Publication Date Title
EP1432709B8 (en) 1-glyoxylamide indolizines for treating cancer
NO20050418L (no) Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet
AU2003257302A1 (en) Phosphonium and imidazolium salts and methods of their preparation
ES2194584A1 (es) Monoacilalquilfosfinas organometalicas.
MX2007012951A (es) Procedimiento para preparar derivados de pirido[2,3-d] pirimidin-7-ona y 3,4-dihidropirimidino[4,5-d]pirimidin-2(1h)-ona.
CO5690577A2 (es) Derivados de imidazoquinolina como ligandos receptores de adenosina a3
NO20052781L (no) Forbindelser og prosesser
WO2008136444A1 (ja) 縮合複素環誘導体
YU160189A (sh) Anelirani derivati tetrahidropiridinocetne kisline in postopki za njihovo pripravo
CA2461060A1 (en) Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
ES2130438T3 (es) Derivados de imidazo(1,2-a)pirazin-4-ona, su preparacion y los medicamentos que les contienen.
DK471586A (da) 3-vinyl- og 3-ethynyl-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel
Ahn et al. Practical synthesis of (S)‐7‐(2‐isopropylamino) ethylcamptothecin hydrochloride, potent topoisomerase I inhibitor
GB0401336D0 (en) Organic compounds
DK118287D0 (da) Heteroaryloxy-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel
HUP0201475A2 (hu) Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
TW200602039A (en) 1-Glyoxylamide indolizines for treating lung and ovarian cancer
DK1303512T3 (da) Fremgangsmåde til fremstilling af arylacetylaminothiazoler
Schantl et al. Expedient synthesis of N-substituted 2-aminothiazoles
AR036735A1 (es) Derivados de 5-metoxi-8-aril-[1,2,4]triazolo[1,5-a]piridina
DK1101756T3 (da) Aminopyrrolinderivater, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
EA200301079A1 (ru) Терапевтическое средство по поводу повышенной чувствительности мочевого пузыря
PE20001035A1 (es) Derivados de benzoxazina y benzotiazina como inhibidores de monoxido de nitrogeno sintasa
NO955071L (no) abeo-Ergolin-derivater som 5HT1A-ligander
SE8003481L (sv) 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)pyrimidin-4-on-derivat jemte sett for deras framstellning

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: CORRECTION OF THE TITLE OF INVENTION FROM 1-GLYOXLYLAMIDE INDOLIZINES FOR TREATING CANCER TO 1-GLYOXYLAMIDE INDOLIZINES FOR TREATING CANCER

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090913